{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9BYF1",
      "entity_text" : "ACE2",
      "entity_type" : "protein"
    },
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uaz:UAZ05341",
      "entity_text" : "SARS-CoV-2",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "uniprot:Q9BYF1",
      "entity_text" : "ACE2",
      "entity_type" : "protein"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "18 Therefore, SARS-CoV-2 binding to ACE2 may decrease residual ACE2 activity and lead to a predominance of ANG II through AT1 receptor signaling.",
  "reading_complete" : "2020-08-02T18:06:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T18:06:16Z",
  "trigger" : "decrease",
  "evidence" : [ "SARS-CoV-2 binding to ACE2 may decrease residual ACE2" ],
  "pmc_id" : "7235302",
  "score" : 0
}